Press Enter to search · ESC to close

Crypto

Novo Nordisk: 40.4% of Obese Children Below Obesity Line in STEP Young

Novo Nordisk announced that in the Phase 3 STEP Young trial, 40.4% of children with obesity achieved a BMI below the obesity threshold. The data highlights the potential of the treatment in pediatric obesity, though specifics of the therapy remain undisclosed.

Original source

Share

Related News

TREE NEWS share card
Long-press image above → Save to Photos / Share
Pitch us Feedback